UCSF

Tagged: HIV

New NIH funding awarded to the Department of Clinical Pharmacy in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Clinical Pharmacy:

The HIV pharmacist: helping patients pick and stick with lifesaving drugs

How do you convince patients who feel fine to take medicines that can have major side effects?

How can you help them stay on their lifesaving daily medications for years to come despite the obstacle course of everyday life?

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support

New drug targeted for Kaposi’s sarcoma

A team of scientists from UCSF and colleagues have identified a new potential drug target for the herpes virus that causes Kaposi’s sarcoma. Their research reopens the possibility of using a class of drugs called protease inhibitors, against diseases ranging from cancer to Alzheimer's Disease.

Clinical pharmacists specialize in AIDS

From the time the antiretroviral therapy AZT was introduced in the 1980s to treat AIDS, the drug demanded close patient monitoring to be effective. AZT had many side effects and strict requirements for how and when to take it. Misuse of the drug could lead to viral resistance.

Hanoi summit on pharmacists and AIDS

UCSF leaders in pharmacy, international health, and AIDS met with their Vietnamese peers in Hanoi this October to plan how Vietnam's pharmacy workforce can curtail the spread of HIV in Vietnam.

Pages